Anterra Therapeutics
Latest round
- Seed
Last raised
- Jun 2016
Total raised
- $1.7M
Investors
- 1
About Anterra Therapeutics
Founded in 2014, Anterra Therapeutics operates out of Boston, US, where it specializes in biotechnology solutions aimed at metabolic conditions. The company has undergone a significant pivot in its strategy to enhance its product offerings. The company has not disclosed any subsidiary or parent company relationships. Anterra Therapeutics focuses on providing innovative biotechnology solutions designed to address the specific needs of its clientele. The company's core offerings include a comprehensive suite of therapeutic applications aimed at treating metabolic diseases. These products are engineered to improve patient outcomes through advanced biological mechanisms. Anterra primarily targets healthcare institutions and pharmaceutical companies in North America and Europe, allowing end users to access therapies that enhance treatment efficacy and patient care. Anterra Therapeutics generates revenue through a structured model combining grants and partnerships with healthcare organizations. Business transactions typically involve collaborative agreements with research institutions, allowing access to its therapeutic products. The company may also engage in partnerships with pharmaceutical firms to broaden its reach and enhance visibility among potential clients. The flagship therapies within its portfolio command premium pricing due to their advanced formulations, enabling healthcare providers to achieve improved patient treatment outcomes. Anterra Therapeutics generates revenue through a structured model combining grants and partnerships with healthcare organizations. Business transactions typically involve collaborative agreements with research institutions, allowing access to its therapeutic products. The company may also engage in partnerships with pharmaceutical firms to broaden its reach and enhance visibility among potential clients. The flagship therapies within its portfolio command premium pricing due to their advanced formulations, enabling healthcare providers to achieve improved patient treatment outcomes.
Who invested in Anterra Therapeutics
1 investor across 1 round
See all investors in Anterra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 1, 2016
Amount
$1.7M
Investors
Questions about Anterra Therapeutics
Who invested in Anterra Therapeutics?
Anterra Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anterra Therapeutics raised?
Anterra Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anterra Therapeutics last raise money?
Anterra Therapeutics's most recent round on record is a Seed, in Jun 2016.
What does Anterra Therapeutics do?
Founded in 2014, Anterra Therapeutics operates out of Boston, US, where it specializes in biotechnology solutions aimed at metabolic conditions.
Where is Anterra Therapeutics headquartered?
Anterra Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Anterra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Anterra Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Anterra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.